Stay updated with breaking news from Nyse age. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AgeX Therapeutics (NYSE:AGE – Get Free Report) and Xenetic Biosciences (NASDAQ:XBIO – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, earnings and dividends. Profitability This table compares AgeX Therapeutics and […] ....
AgeX Therapeutics (NYSE:AGE – Get Free Report) issued its earnings results on Tuesday. The company reported ($0.14) earnings per share for the quarter, reports. The company had revenue of $0.07 million during the quarter. AgeX Therapeutics Stock Performance Shares of AGE stock opened at $0.59 on Friday. AgeX Therapeutics has a 1-year low of $0.37 […] ....
Shares of AgeX Therapeutics, Inc. (NYSE:AGE – Get Free Report) dropped 2.5% during trading on Monday . The stock traded as low as $0.66 and last traded at $0.66. Approximately 7,527 shares changed hands during mid-day trading, a decline of 66% from the average daily volume of 22,098 shares. The stock had previously closed at […] ....
AgeX Therapeutics (NYSE:AGE – Get Free Report) and Gossamer Bio (NASDAQ:GOSS – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, risk, valuation, earnings and dividends. Volatility & Risk AgeX Therapeutics has a […] ....
Susquehanna International Group LLP purchased a new stake in AgeX Therapeutics, Inc. (NYSE:AGE – Get Rating) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 52,381 shares of the company’s stock, valued at approximately $29,000. Separately, Creative Planning raised its stake in shares of AgeX Therapeutics […] ....